Biogen (BIIB) option implied volatility into Clinical Trials on Alzheimer's Congress

Biogen (NASDAQ: BIIB) November weekly option implied volatility is at 22, December weekly is at 55, December is at 56; compared to its 52-week range 29 to 97 into data will be peer reviewed and presented Nov. 29 at the Clinical Trials on Alzheimer's Congress.

You May Also Be Interested In

• Biogen (BIIB) call put ratio 3.7 calls to 1 put with a focus on September calls
• AMD (AMD) call put ratio 1 call to 1.8 put with a focus on August 28 weekly 305 puts
• Micron Technology (MU) call put ratio 1.3 calls to 1 put as share price down 1%